mental health industry
7 Experts Reveal Pharmaceutical Lobbying Sabotages Mental Health Neurodiversity
$7.2 billion in lobbying over the past seven years has been funneled into mental health policy, inflating prescription rates and sidelining neurodivergent care. The money powers campaign contributions, advisory board seats and research grants that prioritise drugs over occupational therapy and other non-pharmacological options. Medical Disclaimer: This article is